{"id":"gen-1124","safety":{"commonSideEffects":[{"rate":"30-50%","effect":"Diarrhea"},{"rate":"20-40%","effect":"Nausea"},{"rate":"10-30%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"GEn-1124 works by inhibiting the PI3K/AKT pathway, which is involved in cell proliferation and survival. This inhibition can lead to the reduction of tumor growth and the induction of apoptosis in cancer cells.","oneSentence":"GEn-1124 is a small molecule that targets the PI3K/AKT pathway.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:01:04.758Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic non-small cell lung cancer"}]},"trialDetails":[{"nctId":"NCT07185113","phase":"PHASE1","title":"A Study to Assess the Pharmacokinetics of GEn-1124 After Single Oral Dosing in Healthy Subjects","status":"RECRUITING","sponsor":"GEn1E Lifesciences","startDate":"2025-10-29","conditions":"Healthy Adult Male","enrollment":6},{"nctId":"NCT05795465","phase":"PHASE2","title":"A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)","status":"RECRUITING","sponsor":"GEn1E Lifesciences","startDate":"2023-04-04","conditions":"Respiratory Distress Syndrome, Acute","enrollment":52}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"GEn-1124","genericName":"GEn-1124","companyName":"GEn1E Lifesciences","companyId":"gen1e-lifesciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"GEn-1124 is a small molecule that targets the PI3K/AKT pathway. Used for Metastatic non-small cell lung cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}